Aimmune’s Palforzia gets FDA approval for treatment of peanut allergy

This article was originally published here

Palforzia, which was formerly known as AR101, has been indicated in the US for the mitigation of anaphylaxis and other allergic reactions following accidental exposure to peanut. The

The post Aimmune’s Palforzia gets FDA approval for treatment of peanut allergy appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply